cholestane-3,5,6-triol has been researched along with Cholangiocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haigh, WG; Ioannou, GN; Jusakul, A; Kuver, R; Loilome, W; Namwat, N; Savard, C; Techasen, A; Yongvanit, P | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and Cholangiocarcinoma
| Article | Year |
|---|---|
Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Cholestanols; Humans; Hydrogen Peroxide; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation | 2013 |